Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01756924
Recruitment Status : Terminated (This study has been terminated; alternative study designs are being considered. Fusidic acid remains available under an Expanded Access Protocol.)
First Posted : December 28, 2012
Last Update Posted : April 19, 2019
Sponsor:
Information provided by (Responsible Party):
Arrevus Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : July 2014
Actual Study Completion Date : July 2014
Certification/Extension First Submitted : November 6, 2014